Agenus | AGEN - Операционные расходы





Операционные расходы Изменить Дата
AbbVie USD 10.52B 258M 2026-09
Agenus USD -199.08M 22.15M 2026-06
Amgen USD 5.69B 6B 2026-09
AstraZeneca USD 11.55B 674M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Celldex Therapeutics USD 649.47M 65.1M 2026-09
CSL USD 5.7B 2.82B 2025-12
Eli Lilly USD 10.52B 496M 2026-06
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Glaxosmithkline GBP 6.76B 1.42B 2026-09
Incyte USD 5.64B 4.67B 2026-09
Intrexon USD 61.56M 26.1M 2024-06
J&J USD 18.93B 1.09B 2026-09
Jiangsu Hengrui CNY 6.01B 449.22M 2026-09
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
MacroGenics USD 42.87M 21.68M 2026-06
Merck EUR 4.34B 249M 2026-06
Merck USD 10.75B 5.02B 2026-09
Northwest Biotherapeutics USD 11.39M 120.04M 2026-03
Novartis USD 9.88B 325M 2026-09
Novavax USD 126.2M 23.62M 2025-12
Pfizer USD 89B 3.81B 2026-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Veracyte USD 133.73M 7.37M 2026-09